Some researches were in accordance with these results which stated that H-TERT expression was limited almost exclusively to cancer cells reporting that the immunohistochemical reactivity of TERT was present in numerous human cancers, including uterine endometrioid and serous carcinoma, but not in benign lesions such as disordered proliferative endometrium and benign endometrial hyperplasia [10, 22]. The gene discussed is TERT; the disease is serous adenocarcinoma.